NPLOC4
Basic information
Region (hg38): 17:81556887-81648465
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPLOC4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 21 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 2 | 3 |
Variants in NPLOC4
This is a list of pathogenic ClinVar variants found in the NPLOC4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-81559289-G-C | not specified | Uncertain significance (Mar 23, 2022) | ||
17-81559353-G-A | Benign (Jun 26, 2018) | |||
17-81559359-G-A | not specified | Uncertain significance (Mar 16, 2024) | ||
17-81559375-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
17-81559378-C-T | not specified | Uncertain significance (Jun 13, 2022) | ||
17-81559396-G-C | Likely benign (Nov 19, 2018) | |||
17-81559406-G-A | Benign (Feb 23, 2018) | |||
17-81565517-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
17-81567475-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
17-81569036-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
17-81569071-G-T | not specified | Uncertain significance (Feb 23, 2023) | ||
17-81569088-A-C | not specified | Uncertain significance (Nov 09, 2021) | ||
17-81572047-C-A | Benign (Dec 31, 2019) | |||
17-81572085-C-T | not specified | Likely benign (Apr 08, 2024) | ||
17-81596166-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
17-81604685-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
17-81606704-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
17-81606711-C-T | not specified | Uncertain significance (Sep 21, 2023) | ||
17-81608811-C-G | not specified | Uncertain significance (Aug 17, 2022) | ||
17-81610230-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
17-81613349-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
17-81613400-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
17-81613411-T-C | not specified | Uncertain significance (Jun 29, 2022) | ||
17-81613420-G-A | not specified | Likely benign (Oct 13, 2023) | ||
17-81622177-C-G | not specified | Uncertain significance (Sep 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPLOC4 | protein_coding | protein_coding | ENST00000331134 | 17 | 91583 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000166 | 124634 | 0 | 4 | 124638 | 0.0000160 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.20 | 185 | 355 | 0.522 | 0.0000209 | 3975 |
Missense in Polyphen | 42 | 141.4 | 0.29704 | 1562 | ||
Synonymous | -0.479 | 153 | 146 | 1.05 | 0.0000100 | 1133 |
Loss of Function | 5.36 | 1 | 35.4 | 0.0283 | 0.00000183 | 407 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000265 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: The ternary complex containing UFD1, VCP and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome. The NPLOC4-UFD1-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope (By similarity). Acts as a negative regulator of type I interferon production via the complex formed with VCP and UFD1, which binds to DDX58/RIG-I and recruits RNF125 to promote ubiquitination and degradation of DDX58/RIG-I (PubMed:26471729). {ECO:0000250|UniProtKB:Q9ES54, ECO:0000269|PubMed:26471729}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);DNA Repair;Translesion Synthesis by POLH;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.57
Haploinsufficiency Scores
- pHI
- 0.259
- hipred
- Y
- hipred_score
- 0.814
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.727
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nploc4
- Phenotype
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;Golgi organization;ubiquitin-dependent ERAD pathway;retrograde protein transport, ER to cytosol;negative regulation of type I interferon production;negative regulation of RIG-I signaling pathway;error-free translesion synthesis
- Cellular component
- nucleus;nucleoplasm;endoplasmic reticulum;cytosol;VCP-NPL4-UFD1 AAA ATPase complex;UFD1-NPL4 complex;nuclear outer membrane-endoplasmic reticulum membrane network
- Molecular function
- protein binding;ubiquitin protein ligase binding;ubiquitin binding;metal ion binding